Celldex Therapeutics logo
Celldex Therapeutics CLDX
$ 26.94 2.75%

Quarterly report 2024-Q3
added 11-06-2024

report update icon

Celldex Therapeutics Operating Cycle 2011-2024 | CLDX

Annual Operating Cycle Celldex Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
78.9 40.2 77.5 69.3 - - - - - - 43.4 1.43 6.7

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
78.9 1.43 45.3

Quarterly Operating Cycle Celldex Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
34.1 76.8 1.55 K - 11.1 244 78.4 - 32.1 95.2 109 - 207 30.5 242 43.4 246 697 47.1 104 170 130 134 164 307 104 56.5 49.6 43.7 44.8 109 86.9 73.3 117 96.4 49.5 86.3 40.6 131 26.4 35.4 65.8 100 72 45.5 460 10.1 1.1 1.29 2 4.01 6.38 6.56 7.95 -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
1.55 K 1.1 131